During the past decade, Impact Clinical Trials conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 12 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Impact Clinical Trials" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Rhythm Pharmaceuticals, Inc." with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "Aderans Research Institute" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Impact Clinical Trials" #1 collaborator was "Accelovance" with 1 trials as a collaborator, "Health Decisions" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Impact Clinical Trials" are "Hypertension" (3 trials), "Hepatitis C" (2 trials), "Opioid-Induced Bowel Dysfunction" (2 trials), "Acute, Uncomplicated Human Influenza" (1 trials) and "Androgenetic Alopecia" (1 trials). Many other conditions were trialed in "Impact Clinical Trials" in a lesser frequency.

Most popular intervention types in "Impact Clinical Trials" are "Drug" (21 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials), "ACH-0141625 (Sovaprevir)" (1 trials) and "Abametapir Lotion 0.74% w/w" (1 trials). Other intervention names were less common.

The vast majority of trials in "Impact Clinical Trials" are 22 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Impact Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Impact Clinical Trials, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Impact Clinical Trials, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".